Fondaparinux is an Anticoagulant Used to Prevent Venous Thromboembolism, Treat Deep Vein Thrombosis and Improve Survival After Myocardial Infarction.
This report contains market size and forecasts of Fondaparinux in Global, including the following market information:
Global Fondaparinux Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Fondaparinux market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Brand Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fondaparinux include Dr. Reddy's Laboratories, Viatris, Abbott, Lee's Pharmaceutical, GlaxoSmithKline, Aspen Pharmacare, Lupin Pharmaceutical, Alchemia and Apicore, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Fondaparinux companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fondaparinux Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Fondaparinux Market Segment Percentages, by Type, 2021 (%)
Brand Drug
Generic Drug
Global Fondaparinux Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Fondaparinux Market Segment Percentages, by Application, 2021 (%)
Deep Vein Thrombosis
Acute Coronary Syndrome
Others
Global Fondaparinux Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Fondaparinux Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fondaparinux revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Fondaparinux revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dr. Reddy's Laboratories
Viatris
Abbott
Lee's Pharmaceutical
GlaxoSmithKline
Aspen Pharmacare
Lupin Pharmaceutical
Alchemia
Apicore
Jiangsu Hengrui Medicine
Kaifeng Pharmaceutical Group
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Fondaparinux Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fondaparinux Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fondaparinux Overall Market Size
2.1 Global Fondaparinux Market Size: 2021 VS 2028
2.2 Global Fondaparinux Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Fondaparinux Players in Global Market
3.2 Top Global Fondaparinux Companies Ranked by Revenue
3.3 Global Fondaparinux Revenue by Companies
3.4 Top 3 and Top 5 Fondaparinux Companies in Global Market, by Revenue in 2021
3.5 Global Companies Fondaparinux Product Type
3.6 Tier 1, Tier 2 and Tier 3 Fondaparinux Players in Global Market
3.6.1 List of Global Tier 1 Fondaparinux Companies
3.6.2 List of Global Tier 2 and Tier 3 Fondaparinux Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Fondaparinux Market Size Markets, 2021 & 2028
4.1.2 Brand Drug
4.1.3 Generic Drug
4.2 By Type - Global Fondaparinux Revenue & Forecasts
4.2.1 By Type - Global Fondaparinux Revenue, 2017-2022
4.2.2 By Type - Global Fondaparinux Revenue, 2023-2028
4.2.3 By Type - Global Fondaparinux Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Fondaparinux Market Size, 2021 & 2028
5.1.2 Deep Vein Thrombosis
5.1.3 Acute Coronary Syndrome
5.1.4 Others
5.2 By Application - Global Fondaparinux Revenue & Forecasts
5.2.1 By Application - Global Fondaparinux Revenue, 2017-2022
5.2.2 By Application - Global Fondaparinux Revenue, 2023-2028
5.2.3 By Application - Global Fondaparinux Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Fondaparinux Market Size, 2021 & 2028
6.2 By Region - Global Fondaparinux Revenue & Forecasts
6.2.1 By Region - Global Fondaparinux Revenue, 2017-2022
6.2.2 By Region - Global Fondaparinux Revenue, 2023-2028
6.2.3 By Region - Global Fondaparinux Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Fondaparinux Revenue, 2017-2028
6.3.2 US Fondaparinux Market Size, 2017-2028
6.3.3 Canada Fondaparinux Market Size, 2017-2028
6.3.4 Mexico Fondaparinux Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Fondaparinux Revenue, 2017-2028
6.4.2 Germany Fondaparinux Market Size, 2017-2028
6.4.3 France Fondaparinux Market Size, 2017-2028
6.4.4 U.K. Fondaparinux Market Size, 2017-2028
6.4.5 Italy Fondaparinux Market Size, 2017-2028
6.4.6 Russia Fondaparinux Market Size, 2017-2028
6.4.7 Nordic Countries Fondaparinux Market Size, 2017-2028
6.4.8 Benelux Fondaparinux Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Fondaparinux Revenue, 2017-2028
6.5.2 China Fondaparinux Market Size, 2017-2028
6.5.3 Japan Fondaparinux Market Size, 2017-2028
6.5.4 South Korea Fondaparinux Market Size, 2017-2028
6.5.5 Southeast Asia Fondaparinux Market Size, 2017-2028
6.5.6 India Fondaparinux Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Fondaparinux Revenue, 2017-2028
6.6.2 Brazil Fondaparinux Market Size, 2017-2028
6.6.3 Argentina Fondaparinux Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Fondaparinux Revenue, 2017-2028
6.7.2 Turkey Fondaparinux Market Size, 2017-2028
6.7.3 Israel Fondaparinux Market Size, 2017-2028
6.7.4 Saudi Arabia Fondaparinux Market Size, 2017-2028
6.7.5 UAE Fondaparinux Market Size, 2017-2028
7 Players Profiles
7.1 Dr. Reddy's Laboratories
7.1.1 Dr. Reddy's Laboratories Corporate Summary
7.1.2 Dr. Reddy's Laboratories Business Overview
7.1.3 Dr. Reddy's Laboratories Fondaparinux Major Product Offerings
7.1.4 Dr. Reddy's Laboratories Fondaparinux Revenue in Global Market (2017-2022)
7.1.5 Dr. Reddy's Laboratories Key News
7.2 Viatris
7.2.1 Viatris Corporate Summary
7.2.2 Viatris Business Overview
7.2.3 Viatris Fondaparinux Major Product Offerings
7.2.4 Viatris Fondaparinux Revenue in Global Market (2017-2022)
7.2.5 Viatris Key News
7.3 Abbott
7.3.1 Abbott Corporate Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Fondaparinux Major Product Offerings
7.3.4 Abbott Fondaparinux Revenue in Global Market (2017-2022)
7.3.5 Abbott Key News
7.4 Lee's Pharmaceutical
7.4.1 Lee's Pharmaceutical Corporate Summary
7.4.2 Lee's Pharmaceutical Business Overview
7.4.3 Lee's Pharmaceutical Fondaparinux Major Product Offerings
7.4.4 Lee's Pharmaceutical Fondaparinux Revenue in Global Market (2017-2022)
7.4.5 Lee's Pharmaceutical Key News
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporate Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Fondaparinux Major Product Offerings
7.5.4 GlaxoSmithKline Fondaparinux Revenue in Global Market (2017-2022)
7.5.5 GlaxoSmithKline Key News
7.6 Aspen Pharmacare
7.6.1 Aspen Pharmacare Corporate Summary
7.6.2 Aspen Pharmacare Business Overview
7.6.3 Aspen Pharmacare Fondaparinux Major Product Offerings
7.6.4 Aspen Pharmacare Fondaparinux Revenue in Global Market (2017-2022)
7.6.5 Aspen Pharmacare Key News
7.7 Lupin Pharmaceutical
7.7.1 Lupin Pharmaceutical Corporate Summary
7.7.2 Lupin Pharmaceutical Business Overview
7.7.3 Lupin Pharmaceutical Fondaparinux Major Product Offerings
7.7.4 Lupin Pharmaceutical Fondaparinux Revenue in Global Market (2017-2022)
7.7.5 Lupin Pharmaceutical Key News
7.8 Alchemia
7.8.1 Alchemia Corporate Summary
7.8.2 Alchemia Business Overview
7.8.3 Alchemia Fondaparinux Major Product Offerings
7.8.4 Alchemia Fondaparinux Revenue in Global Market (2017-2022)
7.8.5 Alchemia Key News
7.9 Apicore
7.9.1 Apicore Corporate Summary
7.9.2 Apicore Business Overview
7.9.3 Apicore Fondaparinux Major Product Offerings
7.9.4 Apicore Fondaparinux Revenue in Global Market (2017-2022)
7.9.5 Apicore Key News
7.10 Jiangsu Hengrui Medicine
7.10.1 Jiangsu Hengrui Medicine Corporate Summary
7.10.2 Jiangsu Hengrui Medicine Business Overview
7.10.3 Jiangsu Hengrui Medicine Fondaparinux Major Product Offerings
7.10.4 Jiangsu Hengrui Medicine Fondaparinux Revenue in Global Market (2017-2022)
7.10.5 Jiangsu Hengrui Medicine Key News
7.11 Kaifeng Pharmaceutical Group
7.11.1 Kaifeng Pharmaceutical Group Corporate Summary
7.11.2 Kaifeng Pharmaceutical Group Business Overview
7.11.3 Kaifeng Pharmaceutical Group Fondaparinux Major Product Offerings
7.11.4 Kaifeng Pharmaceutical Group Fondaparinux Revenue in Global Market (2017-2022)
7.11.5 Kaifeng Pharmaceutical Group Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Fondaparinux Market Opportunities & Trends in Global Market
Table 2. Fondaparinux Market Drivers in Global Market
Table 3. Fondaparinux Market Restraints in Global Market
Table 4. Key Players of Fondaparinux in Global Market
Table 5. Top Fondaparinux Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Fondaparinux Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Fondaparinux Revenue Share by Companies, 2017-2022
Table 8. Global Companies Fondaparinux Product Type
Table 9. List of Global Tier 1 Fondaparinux Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fondaparinux Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Fondaparinux Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Fondaparinux Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Fondaparinux Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Fondaparinux Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Fondaparinux Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Fondaparinux Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Fondaparinux Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Fondaparinux Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Fondaparinux Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Fondaparinux Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Fondaparinux Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Fondaparinux Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Fondaparinux Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Fondaparinux Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Fondaparinux Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Fondaparinux Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Fondaparinux Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Fondaparinux Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Fondaparinux Revenue, (US$, Mn), 2023-2028
Table 30. Dr. Reddy's Laboratories Corporate Summary
Table 31. Dr. Reddy's Laboratories Fondaparinux Product Offerings
Table 32. Dr. Reddy's Laboratories Fondaparinux Revenue (US$, Mn), (2017-2022)
Table 33. Viatris Corporate Summary
Table 34. Viatris Fondaparinux Product Offerings
Table 35. Viatris Fondaparinux Revenue (US$, Mn), (2017-2022)
Table 36. Abbott Corporate Summary
Table 37. Abbott Fondaparinux Product Offerings
Table 38. Abbott Fondaparinux Revenue (US$, Mn), (2017-2022)
Table 39. Lee's Pharmaceutical Corporate Summary
Table 40. Lee's Pharmaceutical Fondaparinux Product Offerings
Table 41. Lee's Pharmaceutical Fondaparinux Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Fondaparinux Product Offerings
Table 44. GlaxoSmithKline Fondaparinux Revenue (US$, Mn), (2017-2022)
Table 45. Aspen Pharmacare Corporate Summary
Table 46. Aspen Pharmacare Fondaparinux Product Offerings
Table 47. Aspen Pharmacare Fondaparinux Revenue (US$, Mn), (2017-2022)
Table 48. Lupin Pharmaceutical Corporate Summary
Table 49. Lupin Pharmaceutical Fondaparinux Product Offerings
Table 50. Lupin Pharmaceutical Fondaparinux Revenue (US$, Mn), (2017-2022)
Table 51. Alchemia Corporate Summary
Table 52. Alchemia Fondaparinux Product Offerings
Table 53. Alchemia Fondaparinux Revenue (US$, Mn), (2017-2022)
Table 54. Apicore Corporate Summary
Table 55. Apicore Fondaparinux Product Offerings
Table 56. Apicore Fondaparinux Revenue (US$, Mn), (2017-2022)
Table 57. Jiangsu Hengrui Medicine Corporate Summary
Table 58. Jiangsu Hengrui Medicine Fondaparinux Product Offerings
Table 59. Jiangsu Hengrui Medicine Fondaparinux Revenue (US$, Mn), (2017-2022)
Table 60. Kaifeng Pharmaceutical Group Corporate Summary
Table 61. Kaifeng Pharmaceutical Group Fondaparinux Product Offerings
Table 62. Kaifeng Pharmaceutical Group Fondaparinux Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Fondaparinux Segment by Type in 2021
Figure 2. Fondaparinux Segment by Application in 2021
Figure 3. Global Fondaparinux Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Fondaparinux Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Fondaparinux Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Fondaparinux Revenue in 2021
Figure 8. By Type - Global Fondaparinux Revenue Market Share, 2017-2028
Figure 9. By Application - Global Fondaparinux Revenue Market Share, 2017-2028
Figure 10. By Region - Global Fondaparinux Revenue Market Share, 2017-2028
Figure 11. By Country - North America Fondaparinux Revenue Market Share, 2017-2028
Figure 12. US Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Fondaparinux Revenue Market Share, 2017-2028
Figure 16. Germany Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 17. France Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Fondaparinux Revenue Market Share, 2017-2028
Figure 24. China Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 28. India Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Fondaparinux Revenue Market Share, 2017-2028
Figure 30. Brazil Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Fondaparinux Revenue Market Share, 2017-2028
Figure 33. Turkey Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Fondaparinux Revenue, (US$, Mn), 2017-2028
Figure 37. Dr. Reddy's Laboratories Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Viatris Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbott Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Lee's Pharmaceutical Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Aspen Pharmacare Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Lupin Pharmaceutical Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Alchemia Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Apicore Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Jiangsu Hengrui Medicine Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Kaifeng Pharmaceutical Group Fondaparinux Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)